Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Abstract
There has been substantial enthusiasm recently regarding the potential role of vitamin D in the primary and secondary prevention of cancer. Laboratory studies demonstrate a range of anticarcinogenic effects for vitamin D compounds, but human studies have yielded little consistent evidence supporting a protective association. Higher circulating levels of vitamin D (i.e., 25-hydroxyvitamin D or 25(OH)D) appear to be associated with reduced risk of colorectal and bladder malignancies, but higher risk of prostate and possibly pancreatic cancers, with no clear association for most other organ sites examined. Despite there being no official institutional recommendations regarding the use of vitamin D supplements for cancer prevention, screenings for vitamin D deficiency and vitamin D supplement use have increased substantially over the past decade. These widespread practices demonstrate that population sociobehavioral changes are often adopted before scientifically well-informed policies and recommendations are available. This review critically examines the currently available epidemiologic literature regarding the associations between circulating 25(OH)D, vitamin D supplementation, and vitamin D-related genetic variation and cancer risk and mortality, with a particular emphasis on prospective studies. We identify several important gaps in our scientific knowledge that should be addressed in order to provide sufficient reproducible data to inform evidence-based recommendations related to optimal 25(OH)D concentrations (and any role for vitamin D supplementation) for the primary and secondary prevention of cancer. With few exceptions, such recommendations cannot be made at this time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dietary Reference Intakes for Calcium and Vitamin D
(2018) · Pediatric Clinical Practice Guidelines & Policies · doi:10.1542/9781610021494-part06-dietary_reference_int · Cited by 2,709
Dietary Reference Intakes for Calcium and Vitamin D
(2011) · National Academies Press eBooks · doi:10.17226/13050 · Cited by 2,551
Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis
Holick, M. F. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.3.362 · Cited by 1,665 · cited 2×
“It is thought that this locally available 1,25(OH)2D is the basis of vitamin D preventive effects for multiple cancers (2, 4).”
BackgroundCommon genetic determinants of vitamin D insufficiency: a genome-wide association study
Wang, T. J., Zhang, F., Richards, J. B., Kestenbaum, B., van Meurs, J. B., Berry, D., Kiel, D. P., Streeten, E. A., Ohlsson, C., Koller, D. L., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60588-0 · Cited by 1,540 · cited 1×
“, 7-dehydrocholesterol reductase gene (DHCR7), cytochrome P450 family 2 subfamily R member 1 gene (CYP2R1), groupspecific component gene (GC), cytochrome P450 family 27 subfamily B member 1 gene (CYP27B1), cytochrome P450 family 24 subfamily A member 1 gene (CYP24A1), and retinoid X receptor α gene (RXRA)) have been c…”
BackgroundVitamin D Status: Measurement, Interpretation, and Clinical Application
Holick, M. F. (2009) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.12.001 · Cited by 1,286 · cited 1×
“25(OH)D is converted to the hormonally active form, 1,25-dihydroxyvitamin D (1,25(OH)2D), by 1αhydroxylase (2, 3) in the kidney and other organs that express the enzyme.”
BackgroundTrivedi, D. P., Doll, R., & Khaw, K. T. (2003) · BMJ · doi:10.1136/bmj.326.7387.469 · Cited by 1,270 · cited 2×
“Trivedi, 2003 (93) 100,000 IU of vitamin D every 4months 135 overall cancer deaths Vitamin D supplement vs.”
BackgroundVitamin D status and ill health: a systematic review
Autier, P., Boniol, M., Pizot, C., & Mullie, P. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70165-7 · Cited by 1,107
Prevalence and correlates of vitamin D deficiency in US adults
Forrest, K. Y. Z., & Stuhldreher, W. L. (2011) · Nutrition Research · doi:10.1016/j.nutres.2010.12.001 · Cited by 942
Genome-wide association study of circulating vitamin D levels
Ahn, J., Yu, K., Stolzenberg-Solomon, R., Simon, K. C., McCullough, M. L., Gallicchio, L., Jacobs, E. J., Ascherio, A., Helzlsouer, K., Jacobs, K. B., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq155 · Cited by 810
Self-citationDeSantis, C. E., Siegel, R. L., Sauer, A. G., Miller, K. D., Fedewa, S. A., Alcaraz, K. I., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21340 · Cited by 790 · cited 2×
“Although it is known that the lower circulating 25(OH)D level in black populations results from the greater melanin pigmentation in darker skin reducing solar ultraviolet B radiation-related cutaneous vitamin D synthesis (113), the reasons for the racial disparities in cancer incidence and mortality have yet to be elu…”
BackgroundChowdhury, R., Kunutsor, S., Vitezova, A., Oliver-Williams, C., Chowdhury, S., Kiefte-de-Jong, J. C., Khan, H., Baena, C. P., Prabhakaran, D., Hoshen, M. B., et al. (2014) · BMJ · doi:10.1136/bmj.g1903 · Cited by 631
The epidemiology of vitamin D and cancer incidence and mortality: A review (United States)
Giovannucci, E. (2005) · Cancer Causes & Control · doi:10.1007/s10552-004-1661-4 · Cited by 598 · cited 4×
“25(OH)D is converted to the hormonally active form, 1,25-dihydroxyvitamin D (1,25(OH)2D), by 1αhydroxylase (2, 3) in the kidney and other organs that express the enzyme.”
BackgroundInfluentialGarland, F. C., Garland, C. F., Gorham, E. D., & Young, J. F. (1990) · Preventive Medicine · doi:10.1016/0091-7435(90)90058-r · Cited by 567 · cited 1×
“Based on the latter, early ecological studies were conducted that suggested that low vitamin D status explained the elevated rates of some cancers in populations living at higher latitudes (1).”
BackgroundManson, J. E., Bassuk, S. S., Lee, I.-M., Cook, N. R., Albert, M. A., Gordon, D., Zaharris, E., MacFadyen, J. G., Danielson, E., Lin, J., et al. (2012) · Contemporary Clinical Trials · doi:10.1016/j.cct.2011.09.009 · Cited by 557 · cited 1×
“Large cancer chemoprevention trials of vitamin D are ongoing, most notably the Vitamin D and Omega-3 (VITAL) trial that has randomized women and men to 2,000 IU/day of vitamin D (plus 1 g of fish oil) or placebo, and should be completed before 2020 (146).”
BackgroundGandini, S., Boniol, M., Haukka, J., Byrnes, G., Cox, B., Sneyd, M. J., Mullie, P., & Autier, P. (2011) · International Journal of Cancer · doi:10.1002/ijc.25439 · Cited by 499 · cited 4×
“Gandini, 2011 (7) Meta-analysis, retrospective (n= 5), and prospective 10 studies Per 25-nmol/L increase”
BackgroundInfluentialFortmann, S. P., Burda, B. U., Senger, C. A., Lin, J. S., & Whitlock, E. P. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-12-201312170-00729 · Cited by 442
Schottker, B., Jorde, R., Peasey, A., Thorand, B., Jansen, E. H. J. M., Groot, L. D., Streppel, M., Gardiner, J., Ordonez-Mena, J. M., Perna, L., et al. (2014) · BMJ · doi:10.1136/bmj.g3656 · Cited by 418 · cited 2×
“Schottker, 2014 (70) Meta-analysis of prospective cohorts 8 studies Highest vs.”
BackgroundDietary supplement use among U.S. adults has increased since NHANES III (1988-1994).
Gahche, J. J., Bailey, R. L., Burt, V. L., Hughes, J. P., Yetley, E. A., Dwyer, J. T., Picciano, M. F., McDowell, M., & Sempos, C. T. (2011) · PubMed · Cited by 395
Ma, Y., Zhang, P., Wang, F., Yang, J., Liu, Z., & Qin, H. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.7566 · Cited by 385 · cited 2×
“(9) reported inverse summary associations for overall colorectal cancer, as well as by anatomical subsite comparing the highest with the lowest quantile of each study.”
BackgroundThe relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature.
Köstner, K., Denzer, N., Müller, F. M., Klein, R., Tilgen, W., & Reichrath, J. (2009) · PubMed · Cited by 384
Vitamin D and prostate cancer: a prediagnostic study with stored sera.
Corder, E. H., Guess, H. A., Hulka, B. S., FRIEDMAN, G. D., Sadler, M. C., Vollmer, R. T., Lobaugh, B., Drezner, M. K., Vogelman∥, J. H., & Orentreich∥, N. (1993) · PubMed · Cited by 356
Circulating 25-Hydroxyvitamin D Levels and Survival in Patients With Colorectal Cancer
Ng, K., Meyerhardt, J. A., Wu, K., Feskanich, D., Hollis, B. W., Giovannucci, E. L., & Fuchs, C. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1027 · Cited by 301
Armas, L. A. G., Dowell, S., Akhter, M., Duthuluru, S., Huerter, C., Hollis, B. W., Lund, R., & Heaney, R. P. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.03.004 · Cited by 284 · cited 1×
“Although it is known that the lower circulating 25(OH)D level in black populations results from the greater melanin pigmentation in darker skin reducing solar ultraviolet B radiation-related cutaneous vitamin D synthesis (113), the reasons for the racial disparities in cancer incidence and mortality have yet to be elu…”
BackgroundAfzal, S., Brondum-Jacobsen, P., Bojesen, S. E., & Nordestgaard, B. G. (2014) · BMJ · doi:10.1136/bmj.g6330 · Cited by 270 · cited 7×
“For example, higher prediagnostic vitamin D status was associated with significantly lower lung cancer mortality in the 2 Danish cohorts (Table 2) (73), but not with colorectal cancermortality (73), and lung cancer mortality was not related to 25(OH)D in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study (80).”
BackgroundInfluentialPlasma vitamin D and mortality in older men: a community-based prospective cohort study
Michaëlsson, K., Baron, J. A., Snellman, G., Gedeborg, R., Byberg, L., Sundström, J., Berglund, L., Ärnlöv, J., Hellman, P., Blomhoff, R., et al. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29749 · Cited by 262
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00603 · Cited by 251
Avenell, A., MacLennan, G. S., Jenkinson, D. J., McPherson, G. C., McDonald, A. M., Pant, P. R., Grant, A. M., Campbell, M. K., Anderson, F. H., Cooper, C., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1309 · Cited by 240
Gallicchio, L., Moore, L. E., Stevens, V. L., Ahn, J., Albanes, D., Hartmuller, V., Setiawan, V. W., Helzlsouer, K. J., Yang, G., Xiang, Y.-B., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq115 · Cited by 237
Self-citationVitamin D supplementation for prevention of cancer in adults
Bjelakovic, G., Gluud, L. L., Nikolova, D., Whitfield, K., Krstic, G., Wetterslev, J., & Gluud, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007469.pub2 · Cited by 212 · cited 6×
“Bjelakovic, 2014 (39) Cochrane Systematic Review 4 trials (including the 3 above); 1,192 cancer deaths Intervention vs.”
BackgroundResultInfluentialMeta-analysis: Serum vitamin D and breast cancer risk
Yin, L., Grandi, N., Raum, E., Haug, U., Arndt, V., & Brenner, H. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.03.037 · Cited by 208
Touvier, M., Chan, D. S. M., Lau, R., Aune, D., Vieira, R., Greenwood, D. C., Kampman, E., Riboli, E., Hercberg, S., & Norat, T. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-1141 · Cited by 205 · cited 2×
“(10) for colon and rectal cancer per 100-IU/L increase in circulating 25(OH)D, whereas Gandini et al.”
BackgroundStandardizing vitamin D assays: The way forward
Binkley, N., Sempos, C. T., & (VDSP), F. T. V. D. S. P. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2252 · Cited by 204
Lee, J. E., Li, H., Chan, A. T., Hollis, B. W., Lee, I.-M., Stampfer, M. J., Wu, K., Giovannucci, E., & Ma, J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0289 · Cited by 200
Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis
Kim, Y., & Je, Y. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.175 · Cited by 197 · cited 2×
“Kim and Je (16) included 14 studies in their meta-analysis and reported no association comparing the highest and lowest categories of circulating 25(OH)D.”
BackgroundLeFevre, M. L., & on behalf of the U.S. Preventive Services Task Force* (2015) · Annals of Internal Medicine · doi:10.7326/m14-2450 · Cited by 190
Stolzenberg-Solomon, R. Z., Jacobs, E. J., Arslan, A. A., Qi, D., Patel, A. V., Helzlsouer, K. J., Weinstein, S. J., McCullough, M. L., Purdue, M. P., Shu, X.-O., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq120 · Cited by 185
Self-citationBauer, S. R., Hankinson, S. E., Bertone-Johnson, E. R., & Ding, E. L. (2013) · Medicine · doi:10.1097/md.0b013e3182943bc2 · Cited by 183
Shui, I. M., Mucci, L. A., Kraft, P., Tamimi, R. M., Lindstrom, S., Penney, K. L., Nimptsch, K., Hollis, B. W., DuPre, N., Platz, E. A., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs189 · Cited by 173 · cited 3×
“A pathway analysis of vitamin D variants (including VDR, CYP27B1, GC, CYP27A1, CYP2R1, CYP24A1, and RXRA) and lethal prostate cancer in the Health Professionals Follow-up Study found significant associations, particularly for VDR and CYP27A1, that were independent of baseline plasma 25(OH)D (Table 2) (91).”
BackgroundMaalmi, H., Ordóñez-Mena, J. M., Schöttker, B., & Brenner, H. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.02.006 · Cited by 165 · cited 4×
“Maalmi, 2014 (79) Meta-analysis, all blood collected from cancer patients after diagnosis 5 studies High vs.”
BackgroundMethodInfluentialMoyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m14-0198 · Cited by 164
Association between low levels of 1,25-dihydroxyvitamin D and breast cancer risk
Janowsky, E. C., Lester, G. E., Weinberg, C. R., Millikan, R. C., Schildkraut, J. M., Garrett, P. A., & Hulka, B. S. (1999) · Public Health Nutrition · doi:10.1017/s1368980099000385 · Cited by 164 · cited 2×
“Ahospital-based case-control study found that pretreatment levels of 25(OH)D and 1,25(OH)2D were not associated with risk in black women (128).”
BackgroundVitamin D Assays: Past and Present Debates, Difficulties, and Developments
Fraser, W. D., & Milan, A. M. (2013) · Calcified Tissue International · doi:10.1007/s00223-012-9693-3 · Cited by 160
Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk
Ahn, J., Albanes, D., Berndt, S. I., Peters, U., Chatterjee, N., Freedman, N. D., Abnet, C. C., Huang, W.-Y., Kibel, A. S., Crawford, E. D., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp055 · Cited by 156
Self-citationPlasma Vitamin D Concentration Influences Survival Outcome After a Diagnosis of Colorectal Cancer
Zgaga, L., Theodoratou, E., Farrington, S. M., Din, F. V. N., Ooi, L. Y., Glodzik, D., Johnston, S., Tenesa, A., Campbell, H., & Dunlop, M. G. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.5947 · Cited by 148 · cited 2×
“On the basis of blood samples taken after diagnosis, a higher level of 25(OH)D was associated with a lower colorectal cancer mortality (82, 83), ovarian cancer mortality (84), and Merkel cell carcinoma mortality (although not significant) (85).”
BackgroundHenderson, C. M., Lutsey, P. L., Misialek, J. R., Laha, T. J., Selvin, E., Eckfeldt, J. H., & Hoofnagle, A. N. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2015.244541 · Cited by 140
Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence
Jacobs, E. T., Kohler, L. N., Kunihiro, A. G., & Jurutka, P. W. (2016) · Journal of Cancer · doi:10.7150/jca.13403 · Cited by 140 · cited 1×
“The current literature also suggests that there may be other important factors that interact with vitamin D status, such as menopausal status in breast cancer (17), sex in colorectal cancer (140), and circulating vitamin D binding protein in prostate cancer (141).”
BackgroundShao, T. H., Klein, P., & Grossbard, M. L. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0278 · Cited by 138
Fedirko, V., Ríboli, E., Tjønneland, A. M., Ferrari, P., Olsen, A., Bueno-de-Mesquita, H. B., van Duijnhoven, F. J. B., Norat, T., Jansen, E. H. J. M., Dahm, C. C., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1065 · Cited by 137
Serum 25-Hydroxyvitamin D and Cancer Mortality in the NHANES III Study (1988–2006)
Freedman, D. M., Looker, A. C., Abnet, C. C., Linet, M. S., & Graubard, B. I. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1420 · Cited by 136
Kristal, A. R., Till, C., Song, X., Tangen, C. M., Goodman, P. J., Neuhauser, M. L., Schenk, J. M., Thompson, I. M., Meyskens, F. L., Goodman, G. E., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0115 · Cited by 135 · cited 4×
“Kristal, 2014 (22) Case-cohort 250 cases ≥75 nmol/L vs.”
ResultInfluentialCaini, S., Boniol, M., Tosti, G., Magi, S., Medri, M., Stanganelli, I., Palli, D., Assedi, M., del Mármol, V., & Gandini, S. (2014) · European Journal of Cancer · doi:10.1016/j.ejca.2014.06.024 · Cited by 134 · cited 2×
“There was also a suggestion that higher levels of 25(OH)D were associated with an increased risk of cutaneous melanoma, although the results were not statistically significant (31) (Table 1).”
ResultMcCullough, M. L., Weinstein, S. J., Freedman, D. M., Helzlsouer, K. J., Flanders, W. D., Koenig, K. L., Kolonel, L. N., Laden, F., Marchand, L. L., Purdue, M. P., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq113 · Cited by 132
Self-citationYin, L., Ordóñez-Mena, J. M., Chen, T., Schöttker, B., Arndt, V., & Brenner, H. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.08.026 · Cited by 124
Xu, Y.-H., Shao, X., Yao, Y., Xu, L., Chang, L., Jiang, Z., & Lin, Z. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1706-3 · Cited by 119
Holick, C. N., Stanford, J. L., Kwon, E. M., Ostrander, E. A., Nejentsev, S., & Peters, U. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0487 · Cited by 119
Low Plasma 25-Hydroxyvitamin D and Risk of Tobacco-Related Cancer
Afzal, S., Bojesen, S. E., & Nordestgaard, B. G. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.201939 · Cited by 118
Stolzenberg‐Solomon, R. Z., & Jacobs, E. J. (2010) · American Journal of Epidemiology · Cited by 115
Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status
Song, M., Nishihara, R., Wang, M., Chan, A. T., Qian, Z. R., Inamura, K., Zhang, X., Ng, K., Kim, S. A., Mima, K., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308852 · Cited by 108
Cancer Incidence and Mortality and Vitamin D in Black and White Male Health Professionals
Giovannucci, E. L., Liu, Y., & Willett, W. C. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0357 · Cited by 107
Plasma 25-Hydroxyvitamin D Levels and the Risk of Colorectal Cancer: The Multiethnic Cohort Study
Woolcott, C. G., Wilkens, L. R., Nomura, A. M. Y., Horst, R. L., Goodman, M. T., Murphy, S. P., Henderson, B. E., Kolonel, L. N., & Le Marchand, L. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0475 · Cited by 104
Plasma 25-Hydroxyvitamin D and Risk of Pancreatic Cancer
Wolpin, B. M., Ng, K., Bao, Y., Kraft, P., Stampfer, M. J., Michaud, D. S., Ma, J., Buring, J. E., Sesso, H. D., Lee, I.-M., et al. (2012) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0836 · Cited by 104 · cited 2×
“(30) showed higher concentrations of 25(OH)D to be associated with a lower risk of pancreatic cancer in a pooled analysis of 5 prospective studies.”
BackgroundVitamin D and Lung Cancer Risk: A Comprehensive Review and Meta-Analysis
Zhang, L., Wang, S., Che, X., & Li, X. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000374072 · Cited by 103 · cited 3×
“Zhang, 2015 (27) Meta-analysis, prospective only 9 studies Highest vs.”
BackgroundInfluentialKomulainen, M., Kröger, H., Tuppurainen, M. T., Heikkinen, A.-M., Alhava, E., Honkanen, R., Jurvelin, J., & Saarikoski, S. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5496 · Cited by 100
Skaaby, T., Husemoen, L. L. N., Thuesen, B. H., Pisinger, C. H., Jørgensen, T., Roswall, N., Larsen, S. C., & Linneberg, A. R. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0007 · Cited by 99 · cited 2×
“Of 2 subsequent prospective studies, 1 conducted in a multiethnic population of postmenopausal women showed an inverse association among white women but no other racial group (19), and the other reported no association (menopausal status was not considered) (20).”
BackgroundKhaw, K., Luben, R., & Wareham, N. J. (2014) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.086413 · Cited by 98
Buttigliero, C., Monagheddu, C., Petroni, P., Saini, A., Dogliotti, L., Ciccone, G., & Berruti, A. (2011) · The Oncologist · doi:10.1634/theoncologist.2011-0098 · Cited by 97
Prediagnostic Plasma Vitamin D Metabolites and Mortality among Patients with Prostate Cancer
Fang, F., Kasperzyk, J. L., Shui, I. M., Hendrickson, W. K., Hollis, B. W., Fall, K., Ma, J., Gaziano, J. M., Stampfer, M. J., Mucci, L. A., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018625 · Cited by 95
Abnet, C. C., Chen, Y., Chow, W., Gao, Y., Helzlsouer, K. J., Marchand, L. L., McCullough, M. L., Shikany, J. M., Virtamo, J., Weinstein, S. J., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq121 · Cited by 93
Self-citationVitamin D Deficiency Predicts Prostate Biopsy Outcomes
Murphy, A. B., Nyame, Y. A., Martin, I. K., Catàlona, W. J., Hollowell, C. M. P., Nadler, R. B., Kozlowski, J. M., Perry, K. T., Kajdacsy‐Balla, A., & Kittles, R. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3085 · Cited by 92
Meta-analysis: Circulating vitamin D and ovarian cancer risk
Yin, L., Grandi, N. C., Raum, E., Haug, U., Arndt, V., & Brenner, H. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.01.023 · Cited by 90
Weinstein, S. J., Stolzenberg‐Solomon, R. Z., Kopp, W., Rager, H., Virtamo, J. R. K., & Albanes, D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2950 · Cited by 90
Self-citationVitamin D pathway gene variants and prostate cancer prognosis
Holt, S. K., Kwon, E. M., Koopmeiners, J. S., Lin, D. W., Feng, Z., Ostrander, E. A., Peters, U., & Stanford, J. L. (2010) · The Prostate · doi:10.1002/pros.21180 · Cited by 89 · cited 5×
“Holt, 2010 (103) Population-based case-control 57 deaths rs11168314 TT vs.”
ResultInfluentialSerum 25-hydroxyvitamin D and breast cancer risk: a meta-analysis of prospective studies
Wang, D., de-la-Paz, O. I. V., Zhai, J.-X., & Liu, D. (2013) · Tumor Biology · doi:10.1007/s13277-013-0929-2 · Cited by 87
Kritchevsky, S. B., Tooze, J. A., Neiberg, R. H., Schwartz, G. G., Hausman, D. B., Johnson, M. A., Bauer, D. C., Cauley, J. A., Shea, M. K., Cawthon, P. M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1551 · Cited by 84
Schenk, J. M., Till, C., Tangen, C. M., Goodman, P. J., Song, X., Torkko, K. C., Kristal, A. R., Peters, U., & Neuhouser, M. L. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1340 · Cited by 79
Brunner, R. L., Wactawski-Wende, J., Caan, B. J., Cochrane, B. B., Chlebowski, R. T., Gass, M. L. S., Jacobs, E. T., LaCroix, A. Z., Lane, D., Larson, J., et al. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.594208 · Cited by 78
Freedman, D. M., Cahoon, E. K., Rajaraman, P., Major, J. M., Doody, M. M., Alexander, B. H., Hoffbeck, R. W., Kimlin, M. G., Graubard, B. I., & Linet, M. S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws223 · Cited by 78 · cited 1×
“Relative to other racial/ethnic groups, populations of African ancestry (hereafter referred to as “black”) are known to be at higher risk for low vitamin D status (110, 111).”
BackgroundGallicchio, L. M., Helzlsouer, K. J., Chow, W., Freedman, D. M., Hankinson, S. E., Hartge, P. A., Hartmuller, V. W., Harvey, C., Hayes, R. B., Horst, R. L., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq116 · Cited by 77
Self-citationKomulainen, M. H. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.546 · Cited by 77
Purdue, M. P., Freedman, D. M., Gapstur, S. M., Helzlsouer, K. J., Laden, F., Lim, U., Maskarinec, G., Rothman, N., Shu, X., Stevens, V. L., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq117 · Cited by 73
Self-citationVitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk
Reimers, L., Crew, K. D., Bradshaw, P. T., Santella, R. M., Steck, S. E., Sirosh, I., Terry, M. B., Hershman, D. L., Shane, E. J., Cremers, S., et al. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0497-9 · Cited by 73
Weinstein, S. J., Purdue, M. P., Smith‐Warner, S. A., Mondul, A. M., Black, A., Ahn, J., Huang, W., Horst, R. L., Kopp, W., Rager, H., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29157 · Cited by 70 · cited 2×
“Two subsequent individual studies also found inverse colorectal cancer associations (11, 12), and 1 other study suggested an increased risk with a higher level of vitamin D for colon cancer (13).”
Self-citationCirculating Vitamin D Levels and Risk of Colorectal Cancer in Women
Chandler, P. D., Buring, J. E., Manson, J. E., Giovannucci, E. L., Moorthy, M. V., Zhang, S., Lee, I.-M. M., & Lin, J. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0470 · Cited by 69 · cited 2×
“Chandler, 2015 (11) Nested case-control 274 colorectal Quartile 4 vs.”
Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies
Pilz, S., Kienreich, K., Tomaschitz, A., Ritz, E., Lerchbaum, E., Obermayer-Pietsch, B., Matzi, V., Lindenmann, J., Marz, W., Gandini, S., et al. (2013) · Anti-Cancer Agents in Medicinal Chemistry- Anti-Cancer Agents) · doi:10.2174/187152013804487407 · Cited by 67 · cited 1×
“(66) concluded that the association between vitamin D and cancer mortality was inconsistent, differing among the 9 studies reviewed, including 1 study with a U-shaped relationship (72).”
ResultGrant, W. B., & Peiris, A. N. (2012) · Dermato-Endocrinology · doi:10.4161/derm.19667 · Cited by 67
Shui, I. M., Mondul, A. M., Lindström, S., Tsilidis, K. K., Travis, R. C., Gerke, T. A., Albanes, D., Mucci, L. A., Giovannucci, E. L., & Kraft, P. L. (2015) · Cancer · doi:10.1002/cncr.29320 · Cited by 65
Self-citationOrlow, I., Reiner, A. S., Thomas, N. E., Roy, P., Kanetsky, P. A., Luo, L., Paine, S., Armstrong, B. K., Kricker, A., Marrett, L. D., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv157 · Cited by 64
Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival
Mondul, A. M., Weinstein, S. J., Moy, K. A., Männistö, S., & Albanes, D. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0991 · Cited by 64
Self-citationSerrano, D., Gnagnarella, P., Raimondi, S., & Gandini, S. (2015) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000132 · Cited by 62 · cited 5×
“For Cdx2, the gg versus GG genotype was associated with an increased risk of overall cancer, but with no statistically significant association with any specific cancer site (44).”
BackgroundInfluentialPoynter, J. N., Jacobs, E. T., Figueiredo, J. C., Lee, W. H., Conti, D. V., Campbell, P. T., Levine, A. J., Limburg, P. J., Marchand, L. L., Cotterchio, M., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0662 · Cited by 62
Vitamin D receptor polymorphismFokIand cancer risk: a comprehensive meta-analysis
Gnagnarella, P., Pasquali, E., Serrano, D., Raimondi, S., Disalvatore, D., & Gandini, S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu150 · Cited by 58
Genetic polymorphisms in the vitamin D pathway in relation to lung cancer risk and survival
Kong, J., Xu, F., Qu, J., Wang, Y., Gao, M., Yu, H., & Qian, B. (2014) · Oncotarget · doi:10.18632/oncotarget.2951 · Cited by 56 · cited 1×
“Studies using a candidate SNP approach have found individual SNPs in vitamin Drelated genes to be associated with several cancers, but these findings have not been replicated in the more comprehensive studies (51, 54, 57, 62) (data not shown in Table 1).”
ResultCirculating 25‐hydroxyvitamin D, vitamin D‐binding protein and risk of prostate cancer
Weinstein, S. J., Mondul, A. M., Kopp, W., Rager, H., Virtamo, J. R. K., & Albanes, D. (2012) · International Journal of Cancer · doi:10.1002/ijc.27969 · Cited by 54
Self-citationVitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma
Cho, M. T., Peddi, P. F., Ding, K., Chen, L., Thomas, D., Wang, J., Lockhart, A. C., Tan, B. R., & Wang‐Gillam, A. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-206 · Cited by 52
Obara, W., Suzuki, Y. A., Kato, K., Tanji, S., Konda, R., & Fujioka, T. (2007) · International Journal of Urology · doi:10.1111/j.1442-2042.2007.01771.x · Cited by 52
Kim, Y.-J., Franke, A. A., Shvetsov, Y. B., Wilkens, L. R., Cooney, R. V., Lurie, G., Maskarinec, G., Hernandez, B. Y., Marchand, L. L., Henderson, B. E., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-29 · Cited by 51 · cited 4×
“Kim, 2014 (19) Nested case-control 707 Per 50-nmol/L increase (white women) 0.”
BackgroundInfluentialCirculating 25-hydroxyvitamin D and risk of lung cancer: a dose–response meta-analysis
Chen, G., Zhang, Z., Wan, Z., Wang, L., Weber, P., Eggersdorfer, M. L., Qin, L., & Zhang, W. (2015) · Cancer Causes & Control · doi:10.1007/s10552-015-0665-6 · Cited by 51
Mondul, A. M., Shui, I. M., Yu, K. F., Travis, R. C., Stevens, V. L., Campa, D., Schumacher, F. R., Ziegler, R. G., Bueno-de-Mesquita, H. B., Berndt, S. I., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0007-t · Cited by 49 · cited 2×
“By contrast, of 2 studies of prostate cancer, 1 showed an increased risk of aggressive disease with more SNPs associated with higher levels of 25(OH)D (65), and the other found an increased risk of high-grade disease (50) (Table 1).”
BackgroundResultSelf-citationVitamin D Deficiency and Increased Risk of Bladder Carcinoma: A Meta-Analysis
Zhang, H., Zhang, H., Wen, X., Zhang, Y., Wei, X., & Liu, T. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000438534 · Cited by 49 · cited 3×
“Zhang, 2015 (24) Meta-analysis, retrospective (n= 3), and prospective 7 studies Highest vs.”
BackgroundInfluentialSerum 25-Hydroxy Vitamin D and Survival in Advanced Colorectal Cancer: A Retrospective Analysis
Wesa, K. M., Segal, N. H., Cronin, A. M., Sjoberg, D. D., Jacobs, G., Coleton, M. I., Fleisher, M., Dnistrian, A. M., Saltz, L. B., & Cassileth, B. R. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.998838 · Cited by 48 · cited 2×
“Wesa, 2015 (82) Blood collected after diagnosis of stage IV colorectal cancer 153 deaths (any cause) ≥75 nmol/L vs.”
BackgroundMondul, A. M., Weinstein, S. J., Virtamo, J. R. K., & Albanes, D. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.417 · Cited by 48
Self-citationVitamin D assessment in primary care: changing patterns of testing
Zhao, S. S., Gardner, K., Taylor, W. G., Marks, E., & Goodson, N. J. (2015) · London Journal of Primary Care · doi:10.1080/17571472.2015.11493430 · Cited by 47 · cited 1×
“One study conducted in the United Kingdom found that the number of requests for vitamin D blood testing increased 11-fold from 2007 to 2012 (136), and data from the National Health and Nutrition Examination Survey demonstrate that vitamin D supplement use has nearly doubled over the past 3 decades in the US population…”
BackgroundRacial disparity in death from colorectal cancer: Does vitamin D deficiency contribute?
Fiscella, K. A., Winters, P., Tancredi, D. J., Hendren, S. K., & Franks, P. J. (2010) · Cancer · doi:10.1002/cncr.25647 · Cited by 47
Zeleniuch‐Jacquotte, A., Gallicchio, L. M., Hartmuller, V. W., Helzlsouer, K. J., McCullough, M. L., Setiawan, V. W., Shu, X., Weinstein, S. J., Weiss, J. M., Arslan, A. A., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq114 · Cited by 46
Self-citationSerum 25-Hydroxyvitamin D and Risks of Colon and Rectal Cancer in Finnish Men
Weinstein, S. J., Yu, K. F., Horst, R. L., Ashby, J., Virtamo, J. R. K., & Albanes, D. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq398 · Cited by 45
Self-citationCirculating levels of 25-hydroxyvitamin D and prostate cancer prognosis
Holt, S. K., Kolb, S., Fu, R., Horst, R. L., Feng, Z., & Stanford, J. L. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2013.07.005 · Cited by 45
Gilbert, R., Bonilla, C., Metcalfe, C., Lewis, S. J., Evans, D. M., Fraser, W. D., Kemp, J. P., Donovan, J., Hamdy, F. C., Neal, D. E., et al. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0500-5 · Cited by 43 · cited 2×
“Gilbert, 2015 (50) Nested case-control 1,275 High vs.”
ResultZhao, Y., Chen, C., Pan, W., Gao, M., He, W., Mao, R., Lin, T., & Huang, J. (2015) · Nutrition · doi:10.1016/j.nut.2015.10.023 · Cited by 43
Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans
Batai, K., Murphy, A. B., Nonn, L., & Kittles, R. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00053 · Cited by 42
Vitamin D Supplementation and Cancer: Review of Randomized Controlled Trials
Lazzeroni, M., Serrano, D., Pilz, S., & Gandini, S. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152013804487281 · Cited by 42
Analysis of SNPs and Haplotypes in Vitamin D Pathway Genes and Renal Cancer Risk
Karami, S., Brennan, P., Rosenberg, P. S., Navrátilová, M., Mateș, D., Zaridze, D. G., Janout, V., Kollárová, H., Bencko, V., Matveev, V., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007013 · Cited by 40 · cited 11×
“Karami, 2009 (56) Hospital-based case-control 777 Kidney”
BackgroundInfluentialThe Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation
Robsahm, T. E., Schwartz, G. G., & Tretli, S. (2013) · Cancers · doi:10.3390/cancers5041439 · Cited by 40
Anic, G. M., Thompson, R. C., Nabors, B., Olson, J. J., Browning, J. E., Madden, M. H., Murtagh, F. R., Forsyth, P. A., & Egan, K. M. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-0018-7 · Cited by 40
Clendenen, T. V., Ge, W., Koenig, K. L., Axelsson, T., Liu, M., Afanasyeva, Y., Andersson, A., Arslan, A. A., Chen, Y., Hallmans, G., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140478 · Cited by 37
Serum vitamin D, vitamin D binding protein, and lung cancer survival
Anic, G. M., Weinstein, S. J., Mondul, A. M., Männistö, S., & Albanes, D. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.10.008 · Cited by 37 · cited 2×
“Anic, 2014 (80) Prospective cohort of cancer-free individuals 428 lung cancer deaths Highest vs.”
BackgroundSelf-citationHilali, J. E., de Koning, E. J., van Ballegooijen, A. J., Lips, P. T. A. M., Sohl, E., van Marwijk, H., Visser, M., & van Schoor, N. M. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.12.001 · Cited by 36
BsmI polymorphism of vitamin D receptor gene and cancer risk: A comprehensive meta-analysis
Raimondi, S., Pasquali, E., Gnagnarella, P., Serrano, D., Disalvatore, D., Johansson, H. A., & Gandini, S. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.06.001 · Cited by 35
Vitamin D, PTH, and calcium in relation to survival following prostate cancer
Brändstedt, J., Almquist, M., Manjer, J., & Malm, J. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0740-7 · Cited by 34 · cited 2×
“Brändstedt, 2016 (89) Prospective cohort 169 prostate cancer deaths Highest vs.”
BackgroundLiu, Y. Z., Chen, W., Hu, Z., Xu, L., Shu, Y., Pan, S., Dai, J., Jin, G., Ma, H., & Shen, H. (2011) · Chinese Journal of Cancer Research · doi:10.1007/s11670-011-0033-3 · Cited by 34
Genetic Predictors of Circulating 25-Hydroxyvitamin D and Risk of Colorectal Cancer
Hiraki, L. T., Qu, C., Hutter, C. M., Baron, J. A., Berndt, S. I., Bezieau, S., Brenner, H., Caan, B. J., Casey, G., Chang-Claude, J. C., et al. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0209 · Cited by 33 · cited 1×
“Studies of breast and colorectal cancer have found no association between these SNPs and risk of disease (63, 64) (data not shown in Table 1).”
BackgroundSamimi, M., Touzé, A., Laude, H., Bidre, E. L., Arnold, F., Carpentier, A., Gardair, C., Carlotti, A., Maubec, E., Dupin, N., et al. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12101 · Cited by 33 · cited 2×
“On the basis of blood samples taken after diagnosis, a higher level of 25(OH)D was associated with a lower colorectal cancer mortality (82, 83), ovarian cancer mortality (84), and Merkel cell carcinoma mortality (although not significant) (85).”
BackgroundHuss, L., Butt, S. T., Borgquist, S., Almquist, M., Malm, J., & Manjer, J. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0413-3 · Cited by 32 · cited 2×
“A U-shaped relationship was observed for prediagnostic 25(OH)D and breast cancer mortality in the Swedish Malmo cohort (81).”
BackgroundMuller, D. C., Fanidi, A., Midttun, Ø., Steffen, A., Dossus, L., Boutron‐Ruault, M., Severi, G., Kuhn, T. E., Katzke, V. A., de la Torre, R. A., et al. (2014) · American Journal of Epidemiology · doi:10.1093/aje/kwu204 · Cited by 30
Yin, J., Liu, H., Yi, X., Wu, W., Amos, C. I., Fang, S., Lee, J. E., Han, J., & Wei, Q. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12437 · Cited by 27
Steck, S. E., Arab, L., Zhang, H., Bensen, J. T., Fontham, E. T. H., Johnson, C. S., Mohler, J. L., Smith, G. J., Su, J., Trump, D. L., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125151 · Cited by 27 · cited 2×
“Studies to date on circulating vitaminD and prostate cancer risk in black men include retrospective, hospitalbased, case-control (120–122), and cross-sectional analyses (123, 124).”
BackgroundPaller, C. J., KANAAN, Y. M., Beyene, D., Naab, T. J., Copeland, R., Tsai, H.-L., Kanarek, N., & Hudson, T. (2015) · The Prostate · doi:10.1002/pros.23018 · Cited by 26 · cited 1×
“Paller, 2015 (121) Hospital-based case-control 90 cases >75 nmol/L vs.”
Tsinovoi, C. L., Xun, P., & He, K. (2015) · Supportive Care in Cancer · doi:10.1007/s00520-015-2945-9 · Cited by 25 · cited 2×
“In patients with stage II colorectal cancer, vitamin D supplementation as assessed by interview after diagnosis was not associated with recurrence or mortality (100).”
BackgroundSerum 25‐hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men
Layne, T. M., Weinstein, S. J., Graubard, B. I., Ma, X., Mayne, S. T., & Albanes, D. (2017) · Cancer · doi:10.1002/cncr.30634 · Cited by 25
Self-citationTsai, C., & Giovannucci, E. L. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2198-0 · Cited by 24
Gupta, D., Trukova, K., Popiel, B., Lammersfeld, C. A., & Vashi, P. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119690 · Cited by 21 · cited 2×
“Gupta, 2015 (88) Blood collected after diagnosis of stage IV prostate cancer 46 deaths (any cause) >80 nmol/L vs.”
BackgroundAshmore, J. H., Gallagher, C. J., Lesko, S. M., Muscat, J. E., Hartman, T. J., & Lazarus, P. J. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0284 · Cited by 20
Zeleniuch‐Jacquotte, A., & Gallicchio, L. M. (2010) · American Journal of Epidemiology · Cited by 19
Deschasaux, M., Souberbielle, J., Latino‐Martel, P., Sutton, A., Charnaux, N., Druesne‐Pecollo, N., Galan, P., Herçberg, S., Clerc, S. L., Kesse‐Guyot, E., et al. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.110510 · Cited by 16
Vitamin D and Cancer: Diversity, Complexity, and Still a Ways to Go
Albanes, D. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0207 · Cited by 7
Self-citationGrant, W. B., Mascitelli, L., & Goldstein, M. R. (2011) · Cancer · doi:10.1002/cncr.27374 · Cited by 3
Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk
Arem, H. E., Yu, K. F., Xiong, X., Moy, K. A., Freedman, N. D., Mayne, S. T., Albanes, D., Arslan, A. A., Austin, M. A., Bamlet, W. R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117574
Self-citationVitamin D Receptor Genotype rs731236 (Taq1) and Breast Cancer Prognosis
Perna, L., Butterbach, K., Haug, U., Schöttker, B., Müller, H., Arndt, V., Holleczek, B., Burwinkel, B., & Brenner, H. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0970-t · cited 2×
“By contrast, the ESTHER II and VERDI analyses showed an association between VDR TaqI and breast cancer mortality, but not other VDR variants (102) (Table 2).”
Result
Cited by
Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32319-0 · Cited by 4,974
Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Gordon, D., Copeland, T., D’Agostino, D., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1809944 · Cited by 1,615
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
Bouillon, R., Marcocci, C., Carmeliet, G., Bikle, D., White, J. H., Dawson-Hughes, B., Lips, P., Munns, C. F., Lazaretti-Castro, M., Giustina, A., et al. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00126 · Cited by 1,143
Vitamin D for the prevention of disease: An Endocrine Society clinical practice guideline
Demay, M. B., Pittas, A. G., Bikle, D. D., Diab, D. L., Kiely, M. E., Lazaretti-Castro, M., Lips, P., Mitchell, D. M., Murad, M. H., Powers, S., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae290 · Cited by 639
Manson, J. E., Bassuk, S. S., & Buring, J. E. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105522 · Cited by 161
Metadata
- Authors
- Mondul, A. M., Weinstein, S. J., Layne, T. M., & Albanes, D.
- Venue
- Epidemiologic Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-01-01
- Volume
- 39
- Issue
- 1
- Pages
- 28-48
- ISSN
- 0193-936X (ISSN-L)
- 1478-6729
- OpenAlex
- W2612646164
- Cited by
- 174
- References
- 137
- FWCI
- 15.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.